ForDoz Pharma Corp logo

ForDoz Pharma Corp

US-based sterile drug product CDMO built for scale.

30 employees · est. 2014 · East Windsor, United States

VS
I+Med logo

I+Med

Manufacture and development of biomedical solutions. Specialists in controlled release and smart nanohydrogels.

118 employees · est. 2013 · Spain

I+Med is the older company (2014 vs 2013); I+Med is the larger of the two.

Side-by-Side Comparison

ForDoz Pharma Corp I+Med
Founded
2014 2013 older
Headquarters
East Windsor, United States Spain
Employees
30 118 larger
Industry
Manufacturing, Pharmaceutical Not tracked yet
Funding Stage
Not tracked yet Grant
Total Funding
Not tracked yet $71.43K
Funding Rounds
Not tracked yet 1
Services
Sterile Drug Product CDMO Services, Conventional and Complex Injectable Manufacturing, Preclinical to Commercial Manufacturing, Proprietary Technology Platforms Not tracked yet
Target Customers
Pharmaceutical Companies, Biotech Firms, Healthcare Institutions, Drug Development Partners Not tracked yet
Taxonomy
Sterile Drug Product Development, Conventional Sterile Injectables, Lyophilized Formulations, Liposomal Drug Delivery, Nanoparticle-Based Systems, Microsphere Drug Delivery, Polymer-Based Controlled Release, In Situ Depot Formulations, Long-Acting Injectables, CDMO (Contract Development And Manufacturing Organization), Complex Injectable Therapeutics, Drug Solubility Enhancement, Sustained Drug Release, Controlled Release Systems, 505(b)(2) Regulatory Pathway Nanohydrogels, Controlled Drug Delivery, Biomedical Engineering, Biotechnology Solutions, Nanotechnology, Drug Release Systems, Regulatory Services, Innovation, Customized Products, Molecular Transportation
Website
fordozpharma.com imasmed.com
ForDoz Pharma Corp logo

About ForDoz Pharma Corp

ForDoz Pharma Corp, headquartered in the United States, operates as a leading CDMO (Contract Development and Manufacturing Organization) specializing in sterile drug products. Established in 2014, the company sets itself apart with its advanced capabilities encompassing conventional sterile injectab...

I+Med logo

About I+Med

I+Med is a pharmaceutical laboratory and manufacturer specializing in the development of biomedical solutions, particularly in the area of controlled release and smart nanohydrogels. Founded in 2013 and headquartered in Spain, the company has positioned itself as a world-leading cooperative in the a...

We will tell you when either one moves

BounceWatch watches ForDoz Pharma Corp and I+Med for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at ForDoz Pharma Corp and I+Med — by email.

Frequently Asked Questions

ForDoz Pharma Corp — US-based sterile drug product CDMO built for scale.. I+Med — Manufacture and development of biomedical solutions. Specialists in controlled release and smart nanohydrogels.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
ForDoz Pharma Corp has raised undisclosed funding while I+Med has raised $71.43K.
ForDoz Pharma Corp and I+Med operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare ForDoz Pharma Corp with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at ForDoz Pharma Corp on 11 Apr 2026, and I+Med on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy